Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home

ClinicalTrials.gov ID: NCT00946231

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00946231. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

HF Assessment With BNP In The Home

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart failure. Enrolled subjects will be trained on the use of the Triage Touch meter for fingerstick BNP assessment; these subjects will then test their BNP levels daily using the Triage Touch product for approximately 60 days.

Study identification

NCT ID: NCT00946231
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Abbott RDx Cardiometabolic; Other
Enrollment: 187 participants

Conditions and interventions

Conditions

Heart Failure

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2009 (Type not available)
Primary completion: Jun 2011 (Actual)
Completion: Oct 2011 (Actual)
Last update posted: Aug 31, 2012

2009 – 2011

United States locations

U.S. sites: 11
U.S. states: 1
U.S. cities: 7

Facility	City	State	ZIP	Site status
Care Clinical Research Corp DBA Beaver Medical Center	Banning	California	92220	—
Scripps Clinic Torrey Pines	La Jolla	California	92037	—
Loma Linda University Medical Center	Loma Linda	California	92354	—
Loma Linda VA Medical Center	Loma Linda	California	92357	—
Mission Internal Medical Group	Mission Viejo	California	92691	—
St. Josephs Hospital	Orange	California	92868	—
University of California Irvine Medical Center	Orange	California	92868	—
Desert Cardiology Center	Rancho Mirage	California	92270	—
UCSD Medical Center	San Diego	California	92103	—
San Diego Cardiac Center	San Diego	California	92123	—
VA- UCSD	San Diego	California	92161	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00946231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 31, 2012 · Synced Nov 14, 2026